Please enable Javascript
Advancements in Oncology: Breast Cancer
Dr. Nerea Lopetegui-Lia on the Implications of DESTINY-Breast06 for Clinical Practice
Nera Lopetegui-Lia, MD
Advancements in Oncology
|
June 14, 2024
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Key Breast Cancer Takeaways From the Advancements in Oncology Event
Dr. Margaret Gatti-Mays
Advancements in Oncology
|
June 13, 2024
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Gatti-Mays on the Biggest Questions in Breast Cancer Right Now
Dr. Margaret Gatti-Mays
Advancements in Oncology
|
June 14, 2024
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
The Evolution of Triple-Negative Breast Cancer Therapy
Dr. Margaret Gatti-Mays
Advancements in Oncology
|
June 14, 2024
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Gaining an Enhanced Understanding of HER2 Expression in Breast Cancer
Dr. Margaret Gatti-Mays
Advancements in Oncology
|
June 12, 2024
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Margaret Gatti-Mays on the Importance of Targeted Therapy in Breast Cancer
Dr. Margaret Gatti-Mays
Advancements in Oncology
|
June 12, 2024
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Key Insights on Emerging Breast Cancer Therapies From Dr. Gatti-Mays
Rob Dillard
Advancements in Oncology
|
June 7, 2024
Dr. Margaret Gatti-Mays, who specializes in breast cancer, delivers key insights on many breast cancer-related topics.
Dr. Gatti-Mays on Treating Patients With Endocrine-Resistant Breast Cancer
Rob Dillard
Advancements in Oncology
|
June 6, 2024
Dr. Margaret Gatti-Mays talks with The Oncology Brothers about the right treatments for endocrine-resistant breast cancer.
Dr. Gatti-Mays on the Optimal Treatment Strategy for Patients With HR-Positive Metastatic Breast Cancer
Rob Dillard
Advancements in Oncology
|
June 6, 2024
Dr. Margaret Gatti-Mays details the treatment options for BC patients in the hormone receptor-positive metastatic setting.
Dr. Gatti-Mays Provides Important Breast Cancer Insights at Oncology Brothers Advancements in Oncology Event
Rob Dillard
Advancements in Oncology
|
June 6, 2024
The Oncology Brothers spoke with Dr. Margaret Gatti-Mays, who provided invaluable insights on hormone receptor-positive BC.
Advertisement
Advertisement
Advertisement
Advertisement